Kathryn E. Wengel - 12 Jun 2023 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Chief TO and Risk Officer
Signature
/s/ Laura McFalls, as attorney-in-fact for Kathryn E. Wengel
Issuer symbol
JNJ
Transactions as of
12 Jun 2023
Net transactions value
-$1,994,400
Form type
4
Filing time
14 Jun 2023, 16:19:45 UTC
Previous filing
15 Feb 2023
Next filing
08 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Sale $1,994,400 -12,465 -16% $160.00 65,934 12 Jun 2023 Direct
holding JNJ Common Stock 59 12 Jun 2023 By 401k F1
holding JNJ Common Stock 281 12 Jun 2023 By ESOP F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/30/2023).
F2 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/30/2023).